Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by jewel9mon Feb 06, 2019 12:06pm

139 Views

Post# 29326617

China data very important

This is going to make the China data and potential deal very important.

If China is happy with the data and sign a deal and make equity investment, then you know that the NA partner is going to move forward to.

If and when China signs a deal, the share price will explode. China data should be ready the end of next week. Then NA to follow and not to forget management is meeting with Wanbang after Chinese new year about SGTL2.

Very exciting times ahead. My opinion is to hold on for now and reap bigger rewards to follow.

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December